Envista Holdings Corp

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The firm operates through the following segments: Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Envista Holdings Corp posts robust 2022 results amidst market challenges

Envista Holdings Corp reported strong 2022 performance with core sales growth and expanded EBITDA margins. Despite Q4 challenges, the company remains optimistic about long-term growth prospects in the dental market. Envista's strategic focus on innovation, operational efficiency, and disciplined growth strategies underpin its commitment to achieving long-term targets and driving shareholder value.

Envista Holdings Corp reports Q1 challenges but sees growth opportunities

Envista Holdings Corp faces challenges in core sales and EBITDA margins in Q1 2023, with a focus on accelerating organic growth and improving the E&C business. Despite short-term uncertainties in China and Russia, the company sees opportunities in expanding margins and driving growth through strategic shifts.

Envista Holdings Corp reports solid Q2 performance amidst market challenges

Envista Holdings Corp (NVST) delivered a resilient performance in Q2 2023, showcasing strengths in core revenue growth, operational improvements, and cash flow generation. While facing challenges in certain segments and regions, the company remains optimistic about achieving its full-year guidance and capitalizing on growth opportunities through strategic initiatives.

Envista Holdings Corp reports positive Q3 performance amidst challenges

Envista Holdings Corp reported positive core growth and margin performance in Q3 2023.
Challenges in the implant business and distribution channels are being addressed through strategic investments.
The company is committed to balancing growth and margin expansion for long-term success.
Envista reaffirms its dedication to navigating challenges and driving future growth.

Envista Holdings Corp reports mixed 2023 performance, eyes growth opportunities

Envista Holdings Corp's 2023 performance showed mixed results with challenges in the global dental market and specific issues impacting segments like Equipment & Consumables. Despite these challenges, the company is focusing on optimizing operations, accelerating key businesses, and navigating short-term issues to drive long-term growth. Envista remains cautiously optimistic about 2024, expecting low single-digit core sales growth and improved margins.

Envista reports modest Q1 growth, eyes China for expansion

Envista Holdings Corp (NVST) reported modest Q1 growth, with a focus on accelerating orthodontic and implant businesses, driving operational improvements, and addressing market challenges.
The company is optimistic about its growth potential in China, aiming to close the gap in market growth in North America and reinvigorate growth in the region.
Envista's strategic investments, focus on cost optimization, and plans for talent acquisition position the company for long-term value creation and success in the industry.

Envista Holdings Corp reports Q2 challenges but sees growth opportunities

Envista Holdings Corp faced challenges with core sales decline and impairment charges but improved free cash flow significantly.
Despite the setbacks, the company made strategic investments and saw growth in active Spark doctors and international expansion.
Envista's focus on market conditions, new appointments, and expanding Spark presents opportunities for future growth and success.

Envista Holdings Corp reports mixed Q3 results, eyes margin improvement

Envista's Q3 performance reflects a mix of strengths and challenges, with opportunities for margin improvement and market expansion.
Strong free cash flow and growth in specific segments demonstrate operational resilience and strategic focus.
Management's optimism for future performance indicates confidence in the company's ability to navigate current market dynamics.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Envista (NVST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

BREA, Calif., Oct. 14, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2020 on Thursday, October 29, 2020. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and...

Envista Schedules Third Quarter 2020 Earnings Call

BREA, Calif., Aug. 31, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020.

Envista Announces Virtual Participation In September Healthcare Conferences

Bausch Health Companies Inc

Bristol-Myers

Cooper Companies

Medtronic

These 5 healthcare stocks look like the sector's best, with downside protection and room for price appreciation even if the market falters.

5 Healthcare Stocks for Good (Portfolio) Health

3D Systems

Henry Schein

Patterson Companies

Procter & Gamble

SmileDirectClub

DENTSPLY SIRONA

Many dentists went out of commission amid the novel coronavirus, but as they open back up, consider these dental stocks to buy. 
The post 7 Dental Stocks to Buy for Long-Term Gains appeared first on InvestorPlace.

7 Dental Stocks to Buy for Long-Term Gains

Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q2 2020 Results - Earnings Call Transcript

BREA, Calif., July 21, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2020 on Thursday, July 30, 2020.

Envista Schedules Second Quarter 2020 Earnings Call

American Electric Power Company

Cintas Corp

Fortive

Global Payments

Hilton Worldwide Holdings

Humana

Ingersoll-Rand

Keurig Dr Pepper Inc

Marriott

NXP Semiconductors

PNC Financial Services

Stryker

UnitedHealth Group

YUM! Brands

Amid a weeks-long rally in stocks, some investors may already have forgotten how painful it was when the market crashed in late February and March.

Deep Dive: These 16 stocks figured prominently in this $39 billion-fund manager’s strategy as markets dove in March

BREA, Calif., May 26, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will virtually participate in the Stifel 2020 Jaws & Paws Conference on May 27, 2020. Amir Aghdaei, President and Chief Executive Officer, will represent the...

Envista To Virtually Present At The Stifel 2020 Jaws & Paws Conference

Taking the long view, NVST looks attractive, as a defensive business should hold up once some semblance of normalcy returns.

Envista Holdings Looks Worth A Flyer Here

BREA, Calif., May 18, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the pricing of its offering of $450,000,000 aggregate principal amount of 2.375% convertible senior notes due 2025 (the "notes") in a private offering to qualified institutional buyers...

Envista Holdings Corporation Prices Upsized $450 Million Convertible Senior Notes Offering

Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q1 2020 Results - Earnings Call Transcript

Envista Holdings (NVST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for Envista Holdings (NVST) This Earnings Season?

Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why the Earnings Surprise Streak Could Continue for Envista (NVST)

Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q4 2019 - Earnings Call Transcript

Align Technology

These two dental products companies battle for investors’ attention. Which stock is more attractive?

Better Buy: Align Technology Vs. Envista

NVST vs. GNNDY: Which Stock Is the Better Value Option?

News for Envista Holdings Corp Stock (NVST)